What does the PATCH trial tell us about tranexamic acid in major trauma? This appraisal examines the distinction between survival and favourable functional recovery at six months, and why the choice of outcome matters when interpreting the trial.
A review of the May 2023 NICE head injury guideline update for adults and children. It discusses CT decisions for patients taking anticoagulants or antiplatelets, tranexamic acid in isolated head injury, hypopituitarism and the implications for emergency department practice.
Can patients have lasting problems after a mild traumatic brain injury despite a normal CT scan? This appraisal examines a prospective cohort study of functional recovery, persistent symptoms and the implications for follow-up, including how the selected population affects interpretation.
What can a specialist prehospital service teach us about a rare emergency airway procedure? This review of London Air Ambulance's 20-year cricothyroidotomy experience separates procedural success from patient survival and considers the implications for training, preparation and interpreting retrospective data.
Does prehospital tranexamic acid improve neurological recovery after moderate or severe head injury? This September 2020 trial appraisal examines the absence of a clear primary-outcome benefit, missing follow-up data, injury severity and how the findings compare with CRASH-3.
A review of the CRASH-3 trial and whether tranexamic acid (TXA) is of benefit in traumatic brain injury patients.